Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

AIM: The aim of this study is to determine the incidence of T790M mutations after progression on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) and median duration on TKI before progression on TKI. METHODS: Records of Rajiv Gandhi Cancer Institute and Research Centre, of pa...

Full description

Saved in:
Bibliographic Details
Published in:Lung India
Main Authors: Babu Koyyala, Venkata Pradeep, Batra, Ullas, Jain, Parveen, Sharma, Mansi, Goyal, Pankaj, Medisetty, Pavani, Jajodia, Ankush, Maheshwari, Udip Dilip
Format: Artigo
Language:Inglês
Published: Medknow Publications & Media Pvt Ltd 2018
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120311/
https://ncbi.nlm.nih.gov/pubmed/30168457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/lungindia.lungindia_451_17
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items